Danggui Beimu Kushen Pill Alleviates Colitis-Induced Inflammation in Mice by Regulating the IL-6/IL-6R and IL-17A/IL-17RA Signaling Pathways
<b>Background/Objectives</b>: Danggui Beimu Kushen pill (DBK) is a traditional Chinese medicine renowned for its efficacy in the treatment of inflammatory conditions. It has been used in the modern clinical treatment of ulcerative colitis (UC). Further research is required to clarify its underlying...
Gardado en:
| Principais autores: | , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
MDPI AG
2025-01-01
|
| Series: | Pharmaceuticals |
| Assuntos: | |
| Acceso en liña: | https://www.mdpi.com/1424-8247/18/2/141 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|